<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Physiol</journal-id><journal-title>BMC Physiology</journal-title><issn pub-type="epub">1472-6793</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1472-6793-7-3</article-id><article-id pub-id-type="pmid">17397547</article-id><article-id pub-id-type="doi">10.1186/1472-6793-7-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Regulatory network of inflammation downstream of proteinase-activated receptors</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Saban</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ricardo-saban@ouhsc.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>D'Andrea</surname><given-names>Michael R</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>mdandrea@prdus.jnj.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Andrade-Gordon</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>pandrade@prdus.jnj.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Derian</surname><given-names>Claudia K</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>cderian@prdus.jnj.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Dozmorov</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>igor-dozmorov@omrf.ouhsc.edu</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Ihnat</surname><given-names>Michael A</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>Michael-inhat@ouhsc.edu</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Hurst</surname><given-names>Robert E</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>robert-hurst@ouhsc.edu</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Simpson</surname><given-names>Cindy</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>cindy-simpson@ouhsc.edu</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Saban</surname><given-names>Marcia R</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Marcia-saban@ouhsc.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Physiology, The University Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA</aff><aff id="I2"><label>2</label>J&#x00026;J Pharmaceutical Research and Development Spring House, PA 19477-0776, USA</aff><aff id="I3"><label>3</label>Oklahoma Medical Research Foundation (OMRF), Arthritis and Immunology Research Program, Microarray/Euk. Genomics Core Facility, Oklahoma City, Oklahoma 73104, USA</aff><aff id="I4"><label>4</label>Department of Cell Biology, The University Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA</aff><aff id="I5"><label>5</label>Department of Urology, The University Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>30</day><month>3</month><year>2007</year></pub-date><volume>7</volume><fpage>3</fpage><lpage>3</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-6793/7/3"/><history><date date-type="received"><day>15</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>30</day><month>3</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Saban et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Saban et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Saban Ricardo ricardo-saban@ouhsc.edu </dc:author><dc:title> Regulatory network of inflammation downstream of proteinase-activated receptors </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Physiology 7(1): 3-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1472-6793(2007)7:1&#x0003c;3&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1472-6793</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Protease-activated receptors (PAR) are present in the urinary bladder, and their expression is altered in response to inflammation. PARs are a unique class of G protein-coupled that carry their own ligands, which remain cryptic until unmasked by proteolytic cleavage. Although the canonical signal transduction pathway downstream of PAR activation and coupling with various G proteins is known and leads to the rapid transcription of genes involved in inflammation, the effect of PAR activation on the downstream transcriptome is unknown.</p><p>We have shown that intravesical administration of PAR-activating peptides leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as <italic>E. coli </italic>lipopolysaccharide (LPS), substance P (SP), and antigen was strongly attenuated by PAR1- and to a lesser extent by PAR2-deficiency.</p></sec><sec><title>Results</title><p>Here, cDNA array experiments determined inflammatory genes whose expression is dependent on PAR1 activation. For this purpose, we compared the alteration in gene expression in wild type and PAR1<sup>-/- </sup>mice induced by classical pro-inflammatory stimuli (LPS, SP, and antigen). 75 transcripts were considered to be dependent on PAR-1 activation and further annotated <italic>in silico </italic>by Ingenuity Pathways Analysis (IPA) and gene ontology (GO). Selected transcripts were target validated by quantitative PCR (Q-PCR). Among PAR1-dependent transcripts, the following have been implicated in the inflammatory process: <italic>b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2</italic>, and <italic>tnfaip2</italic>. However, a balanced response to signals of injury requires a transient cellular activation of a panel of genes together with inhibitory systems that temper the overwhelming inflammation. In this context, the activation of genes such as <italic>dusp1 </italic>and <italic>nfkbia </italic>seems to counter-balance the inflammatory response to PAR activation by limiting prolonged activation of p38 MAPK and increased cytokine production. In contrast, transcripts such as <italic>arf6 and dcnt1 </italic>that are involved in the mechanism of PAR re-sensitization would tend to perpetuate the inflammatory reaction in response to common pro-inflammatory stimuli.</p></sec><sec><title>Conclusion</title><p>The combination of cDNA array results and genomic networks reveals an overriding participation of PAR1 in bladder inflammation, provides a working model for the involvement of downstream signaling, and evokes testable hypotheses regarding the transcriptome downstream of PAR1 activation.</p><p>It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestation of cystitis.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>In general, inflammation plays a role in most bladder pathologies, including bladder cancer [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>], and represents a defensive reaction to injury caused by physical damage, chemical substances, micro-organisms, or other agents [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. In particular, neurogenic bladder inflammation involves the participation of mast cells and sensory nerves. We previously presented evidence indicating a key role for mast cells and their products in bladder inflammation [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. As a consequence of inflammation, products of mast cell degranulation such as tryptase can be found in the urine of both bladder cancer and cystitis patients [<xref ref-type="bibr" rid="B8">8</xref>]. In addition to tryptase, other serine proteases such as thrombin and trypsin are produced during tissue damage and make important contributions to tissue responses to injury, repair, cell survival, inflammation [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>], and pain [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Tissue responses to these enzymes are modulated by protease-activated receptors (PARs), a unique class of G protein-coupled receptors that use a fascinating mechanism to convert an extracellular proteolytic cleavage event into a trans-membrane signal. These receptors carry their own ligands, which remain cryptic until unmasked by receptor cleavage (for a review, please see references [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]).</p><p>In order to better understand the role of PARs in cystitis, we used a well established mouse model [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>] to determine the relative effect of PAR-specific peptide agonists. Comparison of inflammatory responses in wild type, PAR1- and PAR2-deficient mice, revealed a mandatory role of PAR1 and, to a lesser extent, PAR2 in mediating bladder responses to a variety of pro-inflammatory stimuli [<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Four PARs have been cloned to date, and all four PARs are co-expressed in the mouse bladder urothelium [<xref ref-type="bibr" rid="B24">24</xref>], with PAR2 and PAR3 being the most abundant in the bladder epithelial layer. In addition to the urothelium, PAR1 and PAR2 are also expressed in mouse detrusor muscle, and PAR4 is expressed in mouse peripheral nerves and plexus cell bodies [<xref ref-type="bibr" rid="B24">24</xref>]. Similarly, in rats PAR2, 3, and 4 are expressed in urothelium, detrusor muscle, and bladder nerve fibers, and bladder afferent cells in dorsal root ganglia express PAR2 to 4 [<xref ref-type="bibr" rid="B25">25</xref>]. Confocal microscopy has revealed the co-localization of PAR2, 3, and 4 with protein gene products 9.5 and vanilloid receptor 1, suggesting that PARs are distributed in C-fiber bladder nerves [<xref ref-type="bibr" rid="B25">25</xref>].</p><p>In addition, PARs are differentially modulated during mouse bladder inflammation. Urothelial PAR2 and, to a lesser extent, PAR1 are down-regulated in acute inflammation, whereas PAR3 and PAR4 are up-regulated [<xref ref-type="bibr" rid="B24">24</xref>]. Bladder fibroblasts were found to present a clear demarcation in PAR expression in response to acute and chronic inflammation [<xref ref-type="bibr" rid="B24">24</xref>]. Additional evidence for the participation of PARs in the bladder inflammatory response was the finding that known pro-inflammatory stimuli such as LPS, substance P, and antigen challenge induce an increase in PAR4 RNA within four hours [<xref ref-type="bibr" rid="B20">20</xref>]. Upregulation of PAR protein levels has been shown to be part of rat bladder responses to cyclophosphamide [<xref ref-type="bibr" rid="B25">25</xref>]. Since PAR1 is well represented in the urinary bladder [<xref ref-type="bibr" rid="B24">24</xref>] and its expression is altered in bladder inflammation [<xref ref-type="bibr" rid="B24">24</xref>], we set forth to determine the molecular pathways downstream of PAR1 activation. For this purpose, we used a combination of gene-array technology, data mining using Ingenuity Pathways Analysis (IPA), and gene ontology (GO) annotation.</p><p>The signal transduction pathway downstream of PAR activation and coupling with various G proteins is known and leads to the rapid transcription of genes involved in inflammation [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. However, the exact composition of the transcriptome downstream of PAR activation remains to be determined. Our approach revealed a cascade of PAR1-dependent transcripts involved in apoptosis, cell death, cell cycle, cell growth and proliferation, cell motility, cell-cell interaction, gene expression, immune response, inflammation, renal and urologic development and disease, hematological disease, and cancer.</p><p>The combination of cDNA arrays and <italic>in silico </italic>genomics network analysis reveals an overriding participation of PAR1 receptors in bladder inflammation, provides a working model for the involvement of downstream transcripts, and evokes testable hypotheses regarding the transcriptome downstream of PAR1 activation.</p></sec><sec><title>Results</title><sec><title>Genes downstream of PAR1 activation</title><p>Seventy five genes fulfilled both the criteria of being expressed 3-fold higher after stimulation with SP or LPS and of not changing expression in response to the same stimuli of PAR1<sup>-/- </sup>mice, and were considered to be PAR1-dependent (Additional files <xref ref-type="supplementary-material" rid="S1">1</xref> and <xref ref-type="supplementary-material" rid="S2">2</xref>, Table 1A and 1B). To further annotate this set of genes, we used a web-based entry tool developed by Ingenuity Pathways Analysis [IPA] [<xref ref-type="bibr" rid="B27">27</xref>]to query their knowledge database [<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. The resulting networks contain: <bold>A</bold>- Sub-cellular layout indicating the predominant location for the expression of encoded proteins (Figure <xref ref-type="fig" rid="F1">1</xref>); <bold>B</bold>-Analysis of canonical pathways significantly associated with this group of genes (Figure <xref ref-type="fig" rid="F2">2</xref>), and <bold>C-D- </bold>Biological functions across the entire dataset most significantly associated with this set of genes (Figure <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref>).</p></sec><sec><title>Sub cellular location (Figure <xref ref-type="fig" rid="F1">1</xref>)</title><p>Genes (green) were associated with function (magenta) and localized to each compartment according to IPA and gene ontology. Dotted lines further group the genes by activity or function such as signal transduction, cytoskeleton re-organization and cell motility, carbohydrate metabolism, proteins and enzymes, transcription, and RNA editing. Of note, a particular set of genes such as <italic>dctn1 </italic>and <italic>arf6 </italic>are involved in PAR trafficking, and their function is associated with other PAR1-dependent transcripts with function in the cytoskeleton reorganization.</p></sec><sec><title>Participation of PAR1-dependent genes in canonical pathways (Figure <xref ref-type="fig" rid="F2">2</xref>)</title><p>Overall, PAR1-dependent transcripts belong to several canonical pathways (Figure <xref ref-type="fig" rid="F2">2</xref>). This type of IPA also revealed key genes that are significantly associated with more than one canonical pathway. This is the case of <italic>elk1, nfkbia, hspb1, dusp1, and akt2</italic>. In addition, this analysis indicates pathways such as VEGF and integrins which share common genes, as is the case of those encoding cytoskeleton proteins <italic>actg1 </italic>and <italic>actb</italic>.</p></sec><sec><title>Primary functions associated with PAR1-dependent genes (Figure <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref>)</title><p>Figures <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref> represent biological functions significantly (p &#x0003c; 0.01) associated with PAR1-specific genes. Those included: apoptosis (n = 26 genes); cell death (n = 29); cell survival (n = 10); cancer (n = 29); cellular growth and proliferation (n = 29); cell-to-cell signaling (n = 15); hematological disease (n = 9); cellular movement (n = 16); gene expression (n = 18); immune and lymphatic system development and function (n = 9); immune response/disease (n = 19); and inflammation and inflammatory disease (n = 22). This type of analysis also revealed PAR-1 dependent genes (<italic>upk2, jundD, ptprc</italic>, and <italic>nfkbp1a) </italic>encoding proteins associated with renal and urological diseases. Figure <xref ref-type="fig" rid="F1">1D</xref> also indicates common pathways of PAR1-dependent transcripts shared by inflammation (red) and cancer (green) and revealed possible targets uniquely associated with some of the biological functions.</p></sec><sec><title>Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-based assays</title><p>Of the 19 genes tested by Q-PCR analysis of CHIP isolated from wild type mice challenged with control peptide, PAR1- and PAR2-AP, 4 genes (<italic>adam-3, dctn1, elk1</italic>, and <italic>mmp2</italic>) had their control levels 1.5 times below background (un-transcribed region) and, therefore, their results are not being presented. Results are presented in figure <xref ref-type="fig" rid="F5">5</xref> as averaged Transcription Events Detected Per 1000 Cells for each gene tested and their standard deviations. With the exception of <italic>pla2G1b</italic>, these results indicate that treatment of wild type mice with PAR1- and PAR2-AP induced up-regulation of the following PAR1-dependent genes: <italic>actb, akt2, arf6, ccl7, cd63, dusp1, fkbp1a, nfkbia, phlda1, plaur, s100a10, tnfaip3, ube2h</italic>, and <italic>upk2</italic>.</p></sec><sec><title>PAR-activation of calcium independent PLA<sub>2 </sub>(figures <xref ref-type="fig" rid="F6">6</xref> and <xref ref-type="fig" rid="F7">7</xref>)</title><p>Our cDNA array results indicate that <italic>pla2G1b </italic>encoding a calcium-dependent PLA<sub>2 </sub>was a PAR1-dependent transcript. However, this particular transcript was not validated by Q-PCR of actively-transcribed DNA (Figure <xref ref-type="fig" rid="F5">5</xref>). Because of the prominent role of the calcium-independent phospholipase A<sub>2 </sub>(iPLA<sub>2</sub>) in mediating tryptase-activated PAR in bladder microvascular endothelial cells [<xref ref-type="bibr" rid="B30">30</xref>], bladder urothelial cells [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>], and PAR2-AP in bladder contractions [<xref ref-type="bibr" rid="B33">33</xref>], we decided to determine whether bladder instillation with PAR-APs also induced up-regulation of iPLA<sub>2 </sub>in the mouse bladder mucosa. The rationale for using only the mucosa was to decrease the complexity of the bladder system, getting closer to the urothelial cell in culture used by the other authors [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. For this purpose, cytoplasmic extracts from the bladder mucosa of WT mice instilled with PAR-APs- or control peptide- were subjected to Western Blot analysis to measure relative concentration of iPLA<sub>2</sub>. Results are representative of 4 separate experiments (Figure <xref ref-type="fig" rid="F6">6</xref>). The bar graph shows the average densitometric values (Figure <xref ref-type="fig" rid="F7">7</xref>). When data was normalized with beta-actin used as loading control, the same relationship was observed (data not shown). These data indicate that in the mouse urinary bladder, all PAR-APs induced up-regulation of iPLA<sub>2</sub>.</p></sec></sec><sec><title>Discussion</title><p>Serine proteases that originate from the circulation (coagulation factors), inflammatory cells (mast cell tryptase, neutrophil granzyme A, and proteinase 3), and epithelial and neuronal tissues (trypsins) can specifically regulate cells by cleaving PARs [<xref ref-type="bibr" rid="B34">34</xref>]. Proteases cleave PARs to reveal tethered ligand domains that bind to and activate the cleaved receptors. The proteases that activate PARs are often generated and secreted during injury and inflammation, and PARs orchestrate tissue responses to these insults, including hemostasis, inflammation, nociception, and repair mechanisms [<xref ref-type="bibr" rid="B34">34</xref>].</p><p>The present results indicated fundamental alterations elicited by pro-inflammatory substances (LPS and SP) in bladder gene-regulation that are mediated by activation of PAR1. The possible mechanisms by which LPS and SP induce PAR activation include degranulation of mast cells with a concomitant release of tryptase and plasma extravasation leading to accumulation of products of the coagulation cascade that activate PARs. However, the activation of PAR in the physiological state is more complex. Although thrombin is a recognized physiological activator of PAR1 and PAR4, the endogenous enzymes responsible for activating PAR2 in urinary bladder are not known. Recently, it was demonstrated that tissue kallikrein family of proteinases are able to regulate PAR signaling and may represent important endogenous regulators PAR1, PAR2, and PAR4 [<xref ref-type="bibr" rid="B35">35</xref>]. Interestingly, the kallikrein family plays a fundamental role in bladder physiology [<xref ref-type="bibr" rid="B36">36</xref>].</p><sec><title>Transcriptional alteration downstream PAR activation</title><p>In terms of mechanism of action, it is well established that after stimulation, PARs couple to various G proteins and activate signal transduction pathways resulting in the rapid transcription of genes that are involved in inflammation [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. However, the response of the transcriptome downstream of PAR activation is not known. Here, we used an approach involving the combination of cDNA arrays, CHIP assay, and <italic>in silico </italic>querying of knowledge databases in order to identify functions dependent of PAR1 activation that are modified during bladder inflammation. Although we clearly defined the criterion for a gene to be named PAR1-dependent (see Methods section), the expression of some/many of these genes may only be indirectly dependent on PAR-1, due to the nature of the downstream cascades and interacting pathways.</p><p>The use of cDNA arrays has contributed immensely to the understanding of inflammation, in general, and the bladder inflammatory transcriptome, in particular [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B38">38</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. In addition, the use of curated networks such as the Ingenuity Pathways Analysis leads to a comprehensive integration of how PAR1-dependent transcripts correlate with canonical pathways and known biological functions. Because our results were obtained with whole bladders, it is not clear whether any single network may be operative in a particular cell type. However, this approach can potentially identify previously unrecognized connections among pathways and, therefore, suggests new hypotheses for the mechanisms of bladder inflammation. Therefore, the value of our approach is to raise testable hypotheses that can be tested in isolated cells or in individual bladder layers. Aberrant expression of protease-activated receptors (PARs) has been associated not only with inflammation but with increased angiogenesis, tumor growth, and metastasis of various cancers [<xref ref-type="bibr" rid="B42">42</xref>-<xref ref-type="bibr" rid="B47">47</xref>]. Therefore, our approach outlined a global visualization of PAR-dependent transcripts (Figure <xref ref-type="fig" rid="F1">1</xref>) as well as their interaction with several pathways (Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>).</p><p>Our results indicated that several genes known to be part of the inflammatory response were found downstream of PAR1 activation (<italic>b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2</italic>, and <italic>tnfaip2)</italic>. The present work adds to this list pro-inflammatory genes such as <italic>wnt6, wisp2, and dvl3 </italic>that belong to the <italic>WNT </italic>family known to be altered in human interstitial cystitis [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. In contrast, some of the proteins encoded by PAR1-dependent transcripts play a role in shutting down the inflammatory cascade. This is the case with type-1 membrane glycoprotein encoded by <italic>Cd200</italic>, which delivers an inhibitory signal cancelling the inflammation-induced macrophage activation [<xref ref-type="bibr" rid="B50">50</xref>]. Within this group, we also highlight <italic>nfkbia</italic>, which encodes IkappaB-alpha, an inhibitor of the NF-kappaB cascade [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B52">52</xref>].</p><p>In addition to genes involved in inflammation, we found upregulation of members of the <italic>tetraspanin </italic>family (<italic>cd63</italic>, and <italic>adam3</italic>) and upk2 that dimerises with the tetraspanin uroplakin 1a. <italic>Cd63 </italic>encodes a protein localized in the membrane of mast cells [<xref ref-type="bibr" rid="B53">53</xref>], and anti-CD63 antibodies inhibit mast cell adhesion to fibronectin and vitronectin [<xref ref-type="bibr" rid="B53">53</xref>]. Adam-3 may have a role in inflammation by regulating the expression of allograft inflammatory factor-1 and iNOS [<xref ref-type="bibr" rid="B54">54</xref>]. <italic>Uroplakin 2 </italic>is a major component of the surface plaques of the urothelium [<xref ref-type="bibr" rid="B55">55</xref>], is found exclusively in differentiated mammalian urothelium [<xref ref-type="bibr" rid="B56">56</xref>], and is a product of terminally-differentiated apical cell layer [<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B58">58</xref>]. In addition to differentiation, uroplakins play a fundamental role in the bladder permeability barrier [<xref ref-type="bibr" rid="B59">59</xref>], wound healing [<xref ref-type="bibr" rid="B60">60</xref>], bacterial adherence and infection [<xref ref-type="bibr" rid="B61">61</xref>], and possibility bladder inflammation [<xref ref-type="bibr" rid="B62">62</xref>]. The present results are the first direct evidence indicating that inflammation <italic>per se </italic>alters the message for uroplakin 2.</p><p>Among the secreted enzymes regulated by PAR1-dependent transcripts is the calcium-dependent phospholipase A<sub>2</sub>, group IB that was up-regulated by LPS- and SP-induced bladder inflammation in wild type mice. Our Q-PCR results did not confirm an up-regulation of transcription in response to PAR1-AP and PAR2-AP. There are several explanations for this discrepancy. One possibility is that the differential expression of RNA was not due to active transcription and therefore, reflects RNA processing. As others have shown that the calcium independent phospholipase A<sub>2 </sub>(iPLA<sub>2</sub>) mediates bladder urothelial [<xref ref-type="bibr" rid="B31">31</xref>], microvascular [<xref ref-type="bibr" rid="B30">30</xref>], and smooth muscle [<xref ref-type="bibr" rid="B33">33</xref>] responses to PAR activation, and has a role in promoting mmp-2-induced cell migration via the phosphatidylinositol 3-kinase &#x02013; Akt pathway [<xref ref-type="bibr" rid="B63">63</xref>], we went further to test whether this calcium-independent PLA is also up-regulated in response to PAR-APs. Our results confirmed upregulation of iPLA<sub>2 </sub>protein in the bladder mucosa of mice instilled with PAR-APs, supporting the upregulation of message levels.</p><p>Another group of genes encodes proteins with roles in signal transduction pathways. Those include: <italic>plaur, actR-IIb, dusp1</italic>, and <italic>akt2. Plaur </italic>encodes the receptor for urokinase plasminogen activator <italic>(u-PA receptor) </italic>and promotes plasmin formation [<xref ref-type="bibr" rid="B64">64</xref>]. <italic>Plaur </italic>is most closely associated with cancer invasion [<xref ref-type="bibr" rid="B65">65</xref>]. A strong correlation exists between PAR mediating the response of thrombin and u-PAR-mediated cancer cell migration/invasion [<xref ref-type="bibr" rid="B42">42</xref>]. <italic>Dusp1 </italic>encodes a dual specificity phosphatase 1 or mitogen-activated protein kinase [MAPK] phosphatase 1, which dephosphorylates and inactivates MAPKs [<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B67">67</xref>].<italic>Dusp1 </italic>regulates a subset of LPS-induced genes [<xref ref-type="bibr" rid="B68">68</xref>] and modulates the anti-inflammatory effects of dexamethasone in macrophages [<xref ref-type="bibr" rid="B66">66</xref>]. <italic>Akt2 </italic>is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. Others have shown that thrombin and PAR- APs induce <italic>Akt2 </italic>phosphorylation [<xref ref-type="bibr" rid="B69">69</xref>,<xref ref-type="bibr" rid="B70">70</xref>]. <italic>Akt2 </italic>is a general protein kinase capable of phosphorylating several known proteins and, therefore, occupies a central position in several signal transduction pathways (Figures <xref ref-type="fig" rid="F1">1B</xref> and <xref ref-type="fig" rid="F1">1C</xref>). Moreover, PAR activation in platelets leads to Akt2 phosphorylation by a mechanism involving either G(12/13) [<xref ref-type="bibr" rid="B69">69</xref>] or G<sub>i </sub>[<xref ref-type="bibr" rid="B71">71</xref>] and Src kinase activation [<xref ref-type="bibr" rid="B69">69</xref>].</p><p>The process of desensitization and re-sensitization of PA receptors is being elucidated [<xref ref-type="bibr" rid="B72">72</xref>]. Agonists of PARs induce an irreversible activation by proteolytic cleavage of the tethered ligand peptides and rapid receptor endocytosis that are targeted to lysosomes [<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B74">74</xref>]. Interestingly, among the PAR1-dependent transcripts, the following encode proteins of the ubiquitin pathway: <italic>mid2, ubr1, pxmp3, ube2h, cul3, and skp1a</italic>. Little is known regarding the alteration of expression of this set of genes during inflammation. However, it has been reported that TNF&#x003b1; stimulates <italic>ube2h </italic>expression by a mechanism involving NF-kappaB [<xref ref-type="bibr" rid="B75">75</xref>]. Together these results raised the intriguing hypothesis that inflammation can induce an increase in the ubiquitin pathway that also modulates the fate of PARs [<xref ref-type="bibr" rid="B76">76</xref>].</p><p><italic>The Rab </italic>family of proteins play a fundamental role in PAR re-sensitization [<xref ref-type="bibr" rid="B77">77</xref>]. Here, we show that <italic>dcnt1 </italic>and <italic>arf6 </italic>also involved in PAR trafficking and are increased during inflammation. <italic>Dcnt1 </italic>is a subunit of the dynein/dynactin complex and an effector for <italic>rab6 </italic>[<xref ref-type="bibr" rid="B78">78</xref>]. This protein is required for the retrograde movement of vesicles and organelles along microtubules [<xref ref-type="bibr" rid="B79">79</xref>]. <italic>Arf6 </italic>is a member of the human ADP-ribosylation factor (<italic>ARF</italic>) family of proteins belonging to the Ras superfamily of small GTPase implicated in vesicle trafficking [<xref ref-type="bibr" rid="B80">80</xref>-<xref ref-type="bibr" rid="B82">82</xref>]. <italic>Arf6 </italic>participates in the endosomal pathway that regulates endocytosis of several receptors [<xref ref-type="bibr" rid="B83">83</xref>]. Post-internalization, <italic>arf6 </italic>and other membrane components are recycled back to the cell surface [<xref ref-type="bibr" rid="B80">80</xref>]. In addition to membrane trafficking, <italic>arf6 </italic>cellular functions include: actin remodeling, cell adhesion, redistribution of &#x003b2;1 integrins, phagocytosis, cell division, and tumor-cell invasion (for a review, see [<xref ref-type="bibr" rid="B80">80</xref>]).</p><p>As alterations in PAR density itself [<xref ref-type="bibr" rid="B25">25</xref>] or in the mechanisms involved in re-sensitization of these receptors can have strong consequences in the shift between homeostasis and inflammation, our results raise the intriguing hypothesis that, in contrast to PAR endocytosis and cessation of the stimulus that occurs during normal physiological responses, inflammation may lead to increased re-cycling of PARs back to the plasma membrane and, therefore, perpetuation of the signal transduction downstream of PAR activation.</p><p>Although the classification by biological function permits a visual association of genes and cellular processes (Figure <xref ref-type="fig" rid="F1">1</xref>), it has the disadvantage of over simplification because several genes may belong to more than one group. This is the case of <italic>mmp2 </italic>(gelatinase A) that is involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes such as inflammation and cancer. Therefore, we constructed figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref>, and <xref ref-type="fig" rid="F4">4</xref> in order to illustrate common pathways involving PAR1-dependent transcripts. This type of association analyses permits the identification of new pathways such as the interaction of PAR1-dependent transcripts with the VEGF-family of growth factors, and suggests explanations of an active role of PAR in angiogenesis [<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B84">84</xref>-<xref ref-type="bibr" rid="B86">86</xref>]. Together, the pathway analysis revealed relevant target for therapeutic interventions to control or to prevent disease progression and bladder inflammation.</p></sec><sec><title>Other cDNA array analysis</title><p>We are aware of a single publication investigating genes downstream of PAR1 activation. This work was performed in a human endothelial cell line challenged with thrombin with the aim of identifying early genes and comparing to those up-regulated in response to leukotriene D4 [<xref ref-type="bibr" rid="B87">87</xref>]. Unfortunately, the referred work did not provide GenBank accession numbers for the PAR1 activated transcripts, which makes comparisons of the results to the current study difficult. Nevertheless, some similarities could be found between their work and the present one. This is the case of <italic>dusp1 </italic>that was found upregulated in both manuscripts. In addition we found adam3, whereas Uzonyi, et al. found another disintegrin-like metalloprotease (adamts1) [<xref ref-type="bibr" rid="B87">87</xref>].</p></sec></sec><sec><title>Conclusion</title><p>This work indicates an overriding participation of PAR1 receptors in bladder inflammation, provides a working model for the involvement of a network of transcripts downstream of PAR1 activation, and evokes testable hypotheses regarding the regulation of PAR. In this context, the activation of genes such as <italic>dusp1 </italic>and <italic>nfkbia </italic>seems to counter balance the inflammatory response to PAR activation by avoiding prolonged activation of p38 MAPK and increased cytokine production [<xref ref-type="bibr" rid="B68">68</xref>]. In contrast, transcripts such as <italic>arf6 and dcnt1 </italic>that are involved in the mechanism of receptor re-sensitization would tend to perpetuate the inflammatory reaction. It remains to be determined whether PAR1 receptor blockade or selective gene silencing transcripts downstream of PAR activation will ameliorate the clinical manifestation of cystitis. Inhibiting of PAR up-regulation using small interfering RNA technology, as confirmed by immunoblotting, should substantially reduced bladder inflammatory response as it has been shown in other systems [<xref ref-type="bibr" rid="B88">88</xref>].</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals</title><p>All animal experimentation described here was performed in conformity with the "Guiding Principles for Research Involving Animals and Human Beings" (OUHSC Animal Care &#x00026; Use Committee protocol #05-088I). PAR1<sup>-/-</sup>[<xref ref-type="bibr" rid="B89">89</xref>] and C57BL/6J mice were used in this research. C57BL/6J mice were used as wild type since PAR1<sup>-/- </sup>was enriched in this background.</p></sec><sec><title>Induction of cystitis</title><p>Acute cystitis was induced in groups of mice, as we described previously [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Briefly, female wild type (C57BL/6J), and PAR-1<sup>-/- </sup>mice were anesthetized (ketamine 200 mg/kg and xylazine 2.5 mg/kg, i.p.), then transurethrally catheterized (24 Ga.; 3/4 in; Angiocath, Becton Dickson, Sandy, Utah), and the urine was drained by applying slight digital pressure to the lower abdomen. The urinary bladders were instilled with 200 &#x003bc;l of one of the following substances: pyrogen-free saline, SP (10 &#x003bc;M), or <italic>Escherichia coli </italic>LPS strain 055:B5 (Sigma, St. Louis, MO; 100 &#x003bc;g/ml). Substances were infused at a slow rate to avoid trauma and vesicoureteral reflux (18). To ensure consistent contact of substances with the bladder, infusion was repeated twice within a 30-min interval, and a 1-ml tuberculin syringe was maintained on the catheter to retain the intravesical solution for 1 hour. After that the catheter was removed and mice were allowed to void normally. Twenty-four hours after instillation, mice were euthanized with pentobarbital (200 mg/kg, i.p.) and bladders removed rapidly.</p></sec><sec><title>Minimum information about microarray experiments &#x02013; MIAME [<xref ref-type="bibr" rid="B90">90</xref>]</title><sec><title>Objective</title><p>To determine the time course of gene-expression in urinary bladders in response to saline, SP, or LPS, challenge of wild type control and PAR1<sup>-/- </sup>mice.</p></sec><sec><title>Array design</title><p>Mouse plastic 5 K Arrays (Clontech, Palo Alto, CA, Cat. #634809). For a complete list of genes present in this array see reference [<xref ref-type="bibr" rid="B91">91</xref>].</p></sec><sec><title>Animal numbers</title><p>Female WT and PAR1<sup>-/- </sup>mice were instilled with saline, SP (10 &#x003bc;M), or <italic>Escherichia coli </italic>LPS strain 055:B5 (Sigma, St. Louis, MO; 100 &#x003bc;g/ml). One group of mice was euthanized at 4 and another at 24 hours following stimulation, the urinary bladders were removed from all groups (n = 8) for RNA extraction.</p></sec><sec><title>Sample preparation for cDNA expression arrays</title><p>We used the same technology as we described before [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Briefly, eight bladders from each group were homogenized together in Ultraspec RNA solution (Biotecx Laboratories Inc. Houston, TX) for isolation and purification of total RNA. Mouse bladders were pooled to ensure enough RNA for gene array analysis. The justification for this approach is that there is not enough RNA in a single mouse bladder for performing cDNA array experiments and the step of purification reduces the amount of total RNA. RNA was DNase-treated according to manufacturer's instructions (Clontech Laboratories, Palo Alto, CA), and the quality of 10 &#x003bc;g was evaluated by denaturing formaldehyde/agarose gel electrophoresis.</p></sec><sec><title>Mouse cDNA expression arrays</title><p>cDNA probes were prepared from DNase-treated RNAs obtained from each of the experimental groups. Five &#x003bc;g of DNase-treated RNA was reverse-transcribed to cDNA and labeled with [&#x003b1;-<sup>33</sup>P]dATP, according to the manufacturer's protocol (Clontech, Palo Alto, CA). The radioactively labeled complex cDNA probes were hybridized overnight to Atlas&#x02122; mouse plastic 5 K arrays (Clontech, Palo Alto, CA) using ExpressHyb&#x02122; hybridization solution with continuous agitation at 68 &#x000b0;C. After two high-stringency washes, the hybridized membranes were exposed (at room temperature) to a ST Cyclone phosphor screen overnight. Spots on the arrays were quantified by BD AtlasImage&#x02122; 2.7 software (Clontech, Palo Alto, CA).</p></sec><sec><title>PAR1-dependent genes. Both the 4 hour and 24 hour time points after inflammation were used to define PAR1-dependent genes</title><p>Data was normalized by a robust linear regression analysis using only genes expressed above background, as described [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>], and the ratio of gene-expression between LPS- and SP-, and saline-challenge was obtained at 4 and 24 hours post-challenge. PAR1<sup>-/- </sup>dependent genes were selected according to the following criterion: <bold>A. </bold>In tissues isolated from WT mice, the expression of particular gene should be up-regulated (ratio between LPS- or SP- and saline-treated &#x0003e; 3.0) in at least one of the time points (4 and 24 hours post-challenge); <bold>B. </bold>in tissues isolated from PAR1<sup>-/- </sup>mice, the expression of same gene should not be altered in response to LPS or SP in any of the time points.</p></sec></sec><sec><title>Database submission of microarray data</title><p>The microarray data have been deposited in the Gene Expression Omnibus (GEO) database [<xref ref-type="bibr" rid="B92">92</xref>]. The samples can be retrieved with GEO accession numbers: GSM144550, GSM144551, GSM144552, GSM144553, GSM144554, GSM144555, GSM144556, GSM144557, GSM144558, GSM144559 that are included in a series (accession number GSE6286).</p></sec><sec><title>Development of the observed interactome of PAR1-specific genes</title><p>Ingenuity Pathways Analysis [IPA], (Ingenuity Systems, Mountain View, CA) is a robust and expertly curated database containing up-to-date information on over 20,000 mammalian genes and proteins, 1.4 million biological interactions, and one hundred canonical pathways incorporating over 6,000 discreet gene concepts. This information is integrated with other relevant databases such as EntrezGene and Gene Ontology [<xref ref-type="bibr" rid="B29">29</xref>]. IPA computes a score for each network according to the fit of the set of supplied focus genes (here, PAR1-dependent genes). These scores, derived from <italic>p </italic>values, indicate the likelihood of focus genes to belong to a network versus those obtained by chance. A score &#x0003e; 2 indicates a &#x02264; 99% confidence that a focus gene network was not generated by chance alone [<xref ref-type="bibr" rid="B93">93</xref>]. The experimental datasets of PAR1-dependent genes was used to query the IPA and to compose a set of interactive networks taking into consideration canonical pathways, the relevant biological interactions, and the cellular and disease processes.</p></sec><sec><title>Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-based assays</title><p>Target validation was sought for 19 of the genes identified from the microarray data as being PAR1-dependent. Female C57BL/6J mice (n = 20 per group) were anesthetized (ketamine 200 mg/kg and xylazine 2.5 mg/kg, i.p.), then transurethrally catheterized (24 Ga.; 3/4 in; Angiocath, Becton Dickson, Sandy, Utah), and the urine was drained by applying slight digital pressure to the lower abdomen. The urinary bladders were instilled with 200 &#x003bc;l of one of the following substances: control inactive peptide (LRGILS [<xref ref-type="bibr" rid="B94">94</xref>]) or PAR-activating peptides (PAR1-AP = SFFLRN [<xref ref-type="bibr" rid="B94">94</xref>]; PAR2-AP = SLIGRL [<xref ref-type="bibr" rid="B94">94</xref>]). Substances were infused at a slow rate to avoid trauma and vesicoureteral reflux (18). To ensure consistent contact of substances with the bladder, infusion was repeated twice within a 30-min interval, and a 1-ml tuberculin syringe was maintained on the catheter end to retain the intravesical solution for 1 hour. After that the catheter was removed and mice were allowed to void normally. Twenty-four hours after instillation, mice were euthanized with pentobarbital (200 mg/kg, i.p.) and bladders removed rapidly and frozen.</p><p>Frozen bladders were shipped to Genpathway [<xref ref-type="bibr" rid="B95">95</xref>] for querying the chromatin for transcription of specific genes (Genpathway's TranscriptionPath Query assay) [<xref ref-type="bibr" rid="B96">96</xref>]. Bladders were exposed briefly to formaldehyde for cross-linking of the proteins and DNA together, followed by sonication to fragment the DNA into pieces of approximately 300&#x02013;500 bp. An antibody against RNA polymerase II (Abcam) was then used to precipitate the DNA transcriptome. The Ab-protein-DNA complexes were purified using beads coupled to protein A. The DNA was isolated from the complexes using a combination of heat to reverse cross-linking, RNase and proteases, and then purified using phenol extraction and EtOH precipitation. The final CHIP DNAs were then used as templates for Q-PCR reactions using primer pairs specific for each gene of interest. Q-PCR was carried out using Taq polymerase (iQ SYBR Green Supermix, Bio-Rad). Primer pairs were designed using Primer 3 [<xref ref-type="bibr" rid="B97">97</xref>]. Details of the primer sequences and the Genebank accession numbers are given in additional material 2 (Table 2). The designed primers shared 100% homology with the target sequence but no significant homology with other sequences.</p><p>Q-PCRs were run in triplicate and the averaged Ct values were transferred into copy numbers of DNA using a standard curve of genomic DNA with known copy numbers. The resulting transcription values for each gene were also normalized for primer pair amplification efficiency using the Q-PCR values obtained with Input DNA (unprecipitated genomic DNA). Results are presented as Transcription Events Detected Per 1000 Cells for each gene tested.</p></sec><sec><title>Tissues for Western Blotting</title><p>Twenty-four hours post-instillation, bladders were rapidly removed and placed in ice cold PBS with protease inhibitors (Complete Protease Inhibitor, Roche, Indianapolis, IN) on ice where the mucosa was dissected away from the detrusor smooth muscle, as described [<xref ref-type="bibr" rid="B32">32</xref>]. Tissues were flash frozen and stored at -80 C until processing. Tissues were pulverized in a spring-loaded tissue pulverizer (Bio-Pulverizer, Biospec Products, Bartlesville, OK) and chilled with liquid nitrogen. Cytosolic extracts were prepared using the Pierce NE-PER Kit that enables stepwise separation and preparation of cytoplasmic and nuclear extracts from bladder tissue. Addition of the first two reagents (Pierce's proprietary information) to the pulverized tissue causes disruption of cell membranes and release of cytoplasmic contents. After recovering the intact nuclei from the cytoplasmic extract by centrifugation at 16,000 &#x000d7; g for 5 minutes, the nuclei are lysed with a third reagent (Pierce's proprietary information) to yield the nuclear extract. Extracts obtained with this product generally have less than 10% contamination between nuclear and cytoplasmic fractions&#x02013;sufficient purity for most experiments involving nuclear extracts. A western blot was prepared using the nuclear and cytosolic extracts and probed for the nuclear proteins histone H3 and lamin A/C. No nuclear contamination was shown in the cytosolic fractions (data not shown). Protein concentrations were determined with a Micro BCA Kit (Pierce, Rockford, IL) per manufacturer's instructions.</p></sec><sec><title>Western Blot</title><p>Immunoblot analyses were performed using 15 &#x003bc;g cytosolic extract loaded onto a 10% tris-glycine SDS gel and run at 125 V for 1.5 hours in tris-glycine SDS running buffer (BioRad, Hercules, CA). The proteins were then transferred to a 0.45 &#x003bc;m nitrocellulose membrane in 1/2 &#x000d7; tris-glycine SDS running buffer with 20% methanol using a BioRad Mini-TransBlot Cell. After blocking in 2% BSA, blots were incubated with rabbit anti-iPLA<sub>2 </sub>(Cayman Chemical, Ann Arbor, MI) at 1:500 overnight at 4&#x000b0;C. An HRP-conjugated anti-rabbit secondary antibody was used for detection at 1:10,000 (Santa Cruz Biotechnology, Santa Cruz, CA) and an enhanced chemiluminescent detection kit (Chemiglow West, Alpha Innotech, San Leandro, CA) was used to visualize. Images were taken using the FluorChem HD digital darkroom (Alpha Innotech, San Leandro, CA) and quantified using ImageJ [<xref ref-type="bibr" rid="B98">98</xref>].</p></sec><sec sec-type="materials"><title>Materials</title><p>PAR-AP &#x02013; PAR1-, PAR2-, and PAR4-AP were synthesized at Molecular Biology Resource Facility, William K. Warren Medical Research Institute, OUHSC, as carboxyl-terminal amides, purified by high-pressure liquid chromatography, and characterized by mass spectroscopy. Peptide solutions were made fresh from powder for most experiments. PAR3-AP was not used in this research because of lack of specificity.</p></sec></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>All authors read and approved the final manuscript. <bold>RS </bold>conceived of the study and drafted the manuscript, <bold>MRD </bold>participated in the design and reviewed the morphological results, <bold>PAG </bold>participated in the experimental design and provided PAR1<sup>-/- </sup>and PAR2<sup>-/- </sup>mice, <bold>CKD </bold>participated in design and proper use of PAR-APS, <bold>ID </bold>performed the statistical analysis of microarray results, <bold>MI </bold>participated in its design and helped to draft the manuscript, <bold>REH </bold>participated in its design and helped to draft the manuscript, <bold>CS </bold>performed the western blotting analysis and helped <bold>MRS </bold>with animal experiments, and <bold>MRS </bold>participated in its design, carried out the animal experiments, removed the tissues, and performed gene array experiments.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p>PAR1-Dependent Transcripts. Table 1</p></caption><media xlink:href="1472-6793-7-3-S1.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p>Primers for Q-PCR. Table 2</p></caption><media xlink:href="1472-6793-7-3-S2.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>Supported by National Institutes of Health grants DK 55828-01 and DK066101-01 (R.S.).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilmy</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>R</given-names></name><name><surname>Bartlett</surname><given-names>JM</given-names></name><name><surname>McNicol</surname><given-names>AM</given-names></name><name><surname>Underwood</surname><given-names>MA</given-names></name><name><surname>McMillan</surname><given-names>DC</given-names></name></person-group><article-title>The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder</article-title><source>Br J Cancer</source><year>2006</year><volume>95</volume><fpage>1234</fpage><lpage>1238</lpage><pub-id pub-id-type="pmid">17024120</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjc.6603415</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>T</given-names></name><name><surname>Nesi</surname><given-names>G</given-names></name><name><surname>Boddi</surname><given-names>V</given-names></name><name><surname>Mazzoli</surname><given-names>S</given-names></name><name><surname>Dal Canto</surname><given-names>M</given-names></name><name><surname>Bartoletti</surname><given-names>R</given-names></name></person-group><article-title>Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma</article-title><source>Oncol Rep</source><year>2006</year><volume>16</volume><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">16820911</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Grossman</surname><given-names>HB</given-names></name><name><surname>Dinney</surname><given-names>CP</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name></person-group><article-title>The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence</article-title><source>Pharmacogenomics</source><year>2005</year><volume>6</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">16142998</pub-id><pub-id pub-id-type="doi">10.2217/14622416.6.6.575</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Offersen</surname><given-names>BV</given-names></name><name><surname>Knap</surname><given-names>MM</given-names></name><name><surname>Marcussen</surname><given-names>N</given-names></name><name><surname>Horsman</surname><given-names>MR</given-names></name><name><surname>Hamilton-Dutoit</surname><given-names>S</given-names></name><name><surname>Overgaard</surname><given-names>J</given-names></name></person-group><article-title>Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis</article-title><source>Br J Cancer</source><year>2002</year><volume>87</volume><fpage>1422</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">12454772</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjc.6600615</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Gerard</surname><given-names>NP</given-names></name><name><surname>Wershil</surname><given-names>BK</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Lack of neurokinin-1 receptor expression affects tissue mast cell numbers but not their spatial relationship with nerves</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2005</year><volume>288</volume><fpage>R491</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">15458971</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Gerard</surname><given-names>NP</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>DeBoer</surname><given-names>DJ</given-names></name><name><surname>Wershil</surname><given-names>BK</given-names></name></person-group><article-title>Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism</article-title><source>Am J Physiol Renal Physiol</source><year>2002</year><volume>283</volume><fpage>F616</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">12217852</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Hammond</surname><given-names>TG</given-names></name><name><surname>Wershil</surname><given-names>BK</given-names></name></person-group><article-title>Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice</article-title><source>Physiol Genomics</source><year>2001</year><volume>7</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11595790</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okragly</surname><given-names>AJ</given-names></name><name><surname>Niles</surname><given-names>AL</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>D</given-names></name><name><surname>Hoffman</surname><given-names>RL</given-names></name><name><surname>Warner</surname><given-names>TF</given-names></name><name><surname>Moon</surname><given-names>TD</given-names></name><name><surname>Uehling</surname><given-names>DT</given-names></name><name><surname>Haak-Frendscho</surname><given-names>M</given-names></name></person-group><article-title>Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients</article-title><source>J Urol</source><year>1999</year><volume>161</volume><fpage>438</fpage><lpage>441</lpage><comment>discussion 441&#x02013;432.</comment><pub-id pub-id-type="pmid">9915421</pub-id><pub-id pub-id-type="doi">10.1016/S0022-5347(01)61915-3</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Cellars</surname><given-names>L</given-names></name><name><surname>Mencarelli</surname><given-names>A</given-names></name><name><surname>Rizzo</surname><given-names>G</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Beck</surname><given-names>P</given-names></name><name><surname>Steinhoff</surname><given-names>M</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name><etal></etal></person-group><article-title>A role for proteinase-activated receptor-1 in inflammatory bowel diseases</article-title><source>Journal of Clinical Investigation</source><year>2004</year><volume>114</volume><fpage>1444</fpage><pub-id pub-id-type="pmid">15545995</pub-id><pub-id pub-id-type="doi">10.1172/JCI200421689</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cenac</surname><given-names>N</given-names></name><name><surname>Garcia-Villar</surname><given-names>R</given-names></name><name><surname>Ferrier</surname><given-names>L</given-names></name><name><surname>Larauche</surname><given-names>M</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Coelho</surname><given-names>AM</given-names></name><name><surname>Fioramonti</surname><given-names>J</given-names></name><name><surname>Bueno</surname><given-names>L</given-names></name></person-group><article-title>Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability</article-title><source>J Immunol</source><year>2003</year><volume>170</volume><fpage>4296</fpage><lpage>4300</lpage><pub-id pub-id-type="pmid">12682265</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidlin</surname><given-names>F</given-names></name><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Dabbagh</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>DE</given-names></name><name><surname>Knott</surname><given-names>P</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Gater</surname><given-names>PR</given-names></name><name><surname>Geppetti</surname><given-names>P</given-names></name><name><surname>Bertrand</surname><given-names>C</given-names></name><name><surname>Stevens</surname><given-names>ME</given-names></name></person-group><article-title>Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>5315</fpage><lpage>5321</lpage><pub-id pub-id-type="pmid">12391252</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steinhoff</surname><given-names>M</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Young</surname><given-names>SH</given-names></name><name><surname>Tognetto</surname><given-names>M</given-names></name><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Ennes</surname><given-names>HS</given-names></name><name><surname>Trevisani</surname><given-names>M</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Caughey</surname><given-names>GH</given-names></name><etal></etal></person-group><article-title>Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism</article-title><source>Nat Med</source><year>2000</year><volume>6</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">10655102</pub-id><pub-id pub-id-type="doi">10.1038/72247</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ossovskaya</surname><given-names>VS</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group><article-title>Protease-activated receptors: contribution to physiology and disease</article-title><source>Physiol Rev</source><year>2004</year><volume>84</volume><fpage>579</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">15044683</pub-id><pub-id pub-id-type="doi">10.1152/physrev.00028.2003</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Nie</surname><given-names>J</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Cottrell</surname><given-names>GS</given-names></name><name><surname>Grady</surname><given-names>EF</given-names></name><name><surname>Trevisani</surname><given-names>M</given-names></name><name><surname>Manni</surname><given-names>C</given-names></name><name><surname>Geppetti</surname><given-names>P</given-names></name><name><surname>McRoberts</surname><given-names>JA</given-names></name><name><surname>Ennes</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>4300</fpage><lpage>4312</lpage><pub-id pub-id-type="pmid">15128844</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5679-03.2004</pub-id></citation></ref><ref id="B15"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>DE</given-names></name><name><surname>Barajas-Lopez</surname><given-names>C</given-names></name><name><surname>Cottrell</surname><given-names>G</given-names></name><name><surname>Velazquez-Rocha</surname><given-names>S</given-names></name><name><surname>Dery</surname><given-names>O</given-names></name><name><surname>Grady</surname><given-names>EF</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Vanner</surname><given-names>S</given-names></name></person-group><article-title>Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea pig submucosal neurons</article-title><source>J Physiol</source><year>2003</year><comment>10.1113/jphysiol.2002.032011.</comment></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name></person-group><article-title>Protease-activated receptors in inflammation, neuronal signaling and pain</article-title><source>Trends Pharmacol Sci</source><year>2001</year><volume>22</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">11239578</pub-id><pub-id pub-id-type="doi">10.1016/S0165-6147(00)01634-5</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>Brussee</surname><given-names>V</given-names></name><name><surname>Compton</surname><given-names>SJ</given-names></name><name><surname>Grady</surname><given-names>EF</given-names></name><name><surname>Cirino</surname><given-names>G</given-names></name><name><surname>Gerard</surname><given-names>N</given-names></name><name><surname>Basbaum</surname><given-names>AI</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>821</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">11433347</pub-id><pub-id pub-id-type="doi">10.1038/89945</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollenberg</surname><given-names>D</given-names></name><name><surname>Compton</surname><given-names>S</given-names></name></person-group><article-title>International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors</article-title><source>Pharmacol Reviews</source><year>2002</year><volume>54</volume><fpage>203</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1124/pr.54.2.203</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name></person-group><article-title>Review article: proteinase-activated receptors &#x02013; novel signals for gastrointestinal pathophysiology</article-title><source>Aliment Pharmacol Ther</source><year>2000</year><volume>14</volume><fpage>257</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">10735917</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2036.2000.00690.x</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Hammond</surname><given-names>TG</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation</article-title><source>Am J Pathol</source><year>2002</year><volume>160</volume><fpage>2095</fpage><lpage>2110</lpage><pub-id pub-id-type="pmid">12057914</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Gene expression profiling of inflammatory bladder disorders</article-title><source>Expert Rev Mol Diagn</source><year>2003</year><volume>3</volume><fpage>217</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">12647997</pub-id><pub-id pub-id-type="doi">10.1586/14737159.3.2.217</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Hammond</surname><given-names>TG</given-names></name><name><surname>Haak-Frendscho</surname><given-names>M</given-names></name><name><surname>Steinberg</surname><given-names>H</given-names></name><name><surname>Tengowski</surname><given-names>MW</given-names></name><name><surname>Bjorling</surname><given-names>DE</given-names></name></person-group><article-title>LPS-sensory peptide communication in experimental cystitis</article-title><source>Am J Physiol Renal Physiol</source><year>2002</year><volume>282</volume><fpage>F202</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">11788433</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Derian</surname><given-names>C</given-names></name><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Ihnat</surname><given-names>MA</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Simpson</surname><given-names>C</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name></person-group><article-title>Mandatory Role of Proteinase-Activated Receptor 1 in Experimental Bladder Inflammation</article-title><source>BMC Physiol</source><year>2007</year><volume>7</volume></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder</article-title><source>Am J Pathol</source><year>2003</year><volume>162</volume><fpage>907</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">12598324</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dattilio</surname><given-names>A</given-names></name><name><surname>Vizzard</surname><given-names>MA</given-names></name></person-group><article-title>Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers</article-title><source>J Urol</source><year>2005</year><volume>173</volume><fpage>635</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">15643279</pub-id><pub-id pub-id-type="doi">10.1097/01.ju.0000143191.55468.1d</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steinhoff</surname><given-names>M</given-names></name><name><surname>Buddenkotte</surname><given-names>J</given-names></name><name><surname>Shpacovitch</surname><given-names>V</given-names></name><name><surname>Rattenholl</surname><given-names>A</given-names></name><name><surname>Moormann</surname><given-names>C</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Luger</surname><given-names>TA</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name></person-group><article-title>Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response</article-title><source>Endocr Rev</source><year>2005</year><volume>26</volume><fpage>1</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">15689571</pub-id><pub-id pub-id-type="doi">10.1210/er.2003-0025</pub-id></citation></ref><ref id="B27"><citation citation-type="other"><ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com"/></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calvano</surname><given-names>SE</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Richards</surname><given-names>DR</given-names></name><name><surname>Felciano</surname><given-names>RM</given-names></name><name><surname>Baker</surname><given-names>HV</given-names></name><name><surname>Cho</surname><given-names>RJ</given-names></name><name><surname>Chen</surname><given-names>RO</given-names></name><name><surname>Brownstein</surname><given-names>BH</given-names></name><name><surname>Cobb</surname><given-names>JP</given-names></name><name><surname>Tschoeke</surname><given-names>SK</given-names></name><etal></etal></person-group><article-title>A network-based analysis of systemic inflammation in humans</article-title><source>Nature</source><year>2005</year><volume>437</volume><fpage>1032</fpage><lpage>1037</lpage><pub-id pub-id-type="pmid">16136080</pub-id><pub-id pub-id-type="doi">10.1038/nature03985</pub-id></citation></ref><ref id="B29"><citation citation-type="other"><article-title>website</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com/"/></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rickard</surname><given-names>A</given-names></name><name><surname>Portell</surname><given-names>C</given-names></name><name><surname>Kell</surname><given-names>PJ</given-names></name><name><surname>Vinson</surname><given-names>SM</given-names></name><name><surname>McHowat</surname><given-names>J</given-names></name></person-group><article-title>Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells</article-title><source>Am J Physiol Renal Physiol</source><year>2005</year><volume>288</volume><fpage>F714</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">15561975</pub-id><pub-id pub-id-type="doi">10.1152/ajprenal.00288.2004</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rickard</surname><given-names>A</given-names></name><name><surname>McHowat</surname><given-names>J</given-names></name></person-group><article-title>Phospholipid metabolite production in human urothelial cells after protease-activated receptor cleavage</article-title><source>Am J Physiol Renal Physiol</source><year>2002</year><volume>283</volume><fpage>F944</fpage><lpage>951</lpage><pub-id pub-id-type="pmid">12372769</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McHowat</surname><given-names>J</given-names></name><name><surname>Creer</surname><given-names>MH</given-names></name><name><surname>Rickard</surname><given-names>A</given-names></name></person-group><article-title>Stimulation of protease activated receptors on RT4 cells mediates arachidonic acid release via Ca2+ independent phospholipase A2</article-title><source>J Urol</source><year>2001</year><volume>165</volume><fpage>2063</fpage><lpage>2067</lpage><pub-id pub-id-type="pmid">11371929</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Nakahara</surname><given-names>T</given-names></name><name><surname>Mitani</surname><given-names>A</given-names></name><name><surname>Maruko</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>K</given-names></name></person-group><article-title>Possible involvement of Ca2+-independent phospholipase A2 in protease-activated receptor-2-mediated contraction of rat urinary bladder</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>2003</year><volume>367</volume><fpage>588</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">12750876</pub-id><pub-id pub-id-type="doi">10.1007/s00210-003-0753-0</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group><article-title>Protease-activated receptors: how proteases signal to cells to cause inflammation and pain</article-title><source>Semin Thromb Hemost</source><year>2006</year><volume>32</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">16673265</pub-id><pub-id pub-id-type="doi">10.1055/s-2006-939553</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oikonomopoulou</surname><given-names>K</given-names></name><name><surname>Hansen</surname><given-names>KK</given-names></name><name><surname>Saifeddine</surname><given-names>M</given-names></name><name><surname>Tea</surname><given-names>I</given-names></name><name><surname>Blaber</surname><given-names>M</given-names></name><name><surname>Blaber</surname><given-names>SI</given-names></name><name><surname>Scarisbrick</surname><given-names>I</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Cottrell</surname><given-names>GS</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><etal></etal></person-group><article-title>Proteinase-activated receptors, targets for kallikrein signaling</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>32095</fpage><lpage>32112</lpage><pub-id pub-id-type="pmid">16885167</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M513138200</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Groat</surname><given-names>WC</given-names></name></person-group><article-title>Integrative control of the lower urinary tract: preclinical perspective</article-title><source>Br J Pharmacol</source><year>2006</year><volume>147</volume><fpage>S25</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16465182</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjp.0706604</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dery</surname><given-names>O</given-names></name><name><surname>Corvera</surname><given-names>CU</given-names></name><name><surname>Steinhoff</surname><given-names>M</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group><article-title>Proteinase-activated receptors: novel mechanisms of signaling by serine proteases</article-title><source>Am J Physiol</source><year>1998</year><volume>274</volume><fpage>C1429</fpage><lpage>1452</lpage><pub-id pub-id-type="pmid">9696685</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Hellmich</surname><given-names>HL</given-names></name><name><surname>Turner</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Vadigepalli</surname><given-names>R</given-names></name><name><surname>Dyer</surname><given-names>DW</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Centola</surname><given-names>M</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa</article-title><source>BMC Physiol</source><year>2006</year><volume>6</volume><fpage>1</fpage><pub-id pub-id-type="pmid">16420690</pub-id><pub-id pub-id-type="doi">10.1186/1472-6793-6-1</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Knowlton</surname><given-names>N</given-names></name><name><surname>Centola</surname><given-names>M</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Connective molecular pathways of experimental bladder inflammation</article-title><source>Physiol Genomics</source><year>2003</year><volume>15</volume><fpage>209</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">12966137</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Gerard</surname><given-names>NP</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Centola</surname><given-names>M</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation</article-title><source>Physiol Genomics</source><year>2003</year><volume>12</volume><fpage>239</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">12499446</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Hellmich</surname><given-names>H</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Winston</surname><given-names>J</given-names></name><name><surname>Hammond</surname><given-names>TG</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation</article-title><source>Physiol Genomics</source><year>2001</year><volume>5</volume><fpage>147</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">11285368</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Del Rosso</surname><given-names>M</given-names></name><name><surname>Fibbi</surname><given-names>G</given-names></name><name><surname>Pucci</surname><given-names>M</given-names></name><name><surname>D'Alessio</surname><given-names>S</given-names></name><name><surname>Del Rosso</surname><given-names>A</given-names></name><name><surname>Magnelli</surname><given-names>L</given-names></name><name><surname>Chiarugi</surname><given-names>V</given-names></name></person-group><article-title>Multiple pathways of cell invasion are regulated by multiple families of serine proteases</article-title><source>Clin Exp Metastasis</source><year>2002</year><volume>19</volume><fpage>193</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">12067200</pub-id><pub-id pub-id-type="doi">10.1023/A:1015531321445</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turcotte</surname><given-names>S</given-names></name><name><surname>Desrosiers</surname><given-names>RR</given-names></name><name><surname>Brand</surname><given-names>G</given-names></name><name><surname>Beliveau</surname><given-names>R</given-names></name></person-group><article-title>von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation</article-title><source>Int J Cancer</source><year>2004</year><volume>112</volume><fpage>777</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">15386385</pub-id><pub-id pub-id-type="doi">10.1002/ijc.20468</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Gangadharan</surname><given-names>B</given-names></name><name><surname>Brass</surname><given-names>LF</given-names></name><name><surname>Ruf</surname><given-names>W</given-names></name><name><surname>Mueller</surname><given-names>BM</given-names></name></person-group><article-title>Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis</article-title><source>Mol Cancer Res</source><year>2004</year><volume>2</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">15280447</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaushal</surname><given-names>V</given-names></name><name><surname>Kohli</surname><given-names>M</given-names></name><name><surname>Dennis</surname><given-names>RA</given-names></name><name><surname>Siegel</surname><given-names>ER</given-names></name><name><surname>Chiles</surname><given-names>WW</given-names></name><name><surname>Mukunyadzi</surname><given-names>P</given-names></name></person-group><article-title>Thrombin receptor expression is upregulated in prostate cancer</article-title><source>Prostate</source><year>2006</year><volume>66</volume><fpage>273</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">16245281</pub-id><pub-id pub-id-type="doi">10.1002/pros.20326</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>TC</given-names></name><name><surname>Lin</surname><given-names>MF</given-names></name></person-group><article-title>Protease-activated receptor 1: a role in prostate cancer metastasis</article-title><source>Clin Prostate Cancer</source><year>2004</year><volume>3</volume><fpage>189</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">15634362</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SR</given-names></name><name><surname>Gallagher</surname><given-names>S</given-names></name><name><surname>Warpeha</surname><given-names>K</given-names></name><name><surname>Hawthorne</surname><given-names>SJ</given-names></name></person-group><article-title>Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors</article-title><source>Prostate</source><year>2004</year><volume>60</volume><fpage>168</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">15162383</pub-id><pub-id pub-id-type="doi">10.1002/pros.20047</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keay</surname><given-names>SK</given-names></name><name><surname>Szekely</surname><given-names>Z</given-names></name><name><surname>Conrads</surname><given-names>TP</given-names></name><name><surname>Veenstra</surname><given-names>TD</given-names></name><name><surname>Barchi</surname><given-names>JJ</given-names><suffix>Jr</suffix></name><name><surname>Zhang</surname><given-names>CO</given-names></name><name><surname>Koch</surname><given-names>KR</given-names></name><name><surname>Michejda</surname><given-names>CJ</given-names></name></person-group><article-title>An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>11803</fpage><lpage>11808</lpage><pub-id pub-id-type="pmid">15282374</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0404509101</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keay</surname><given-names>S</given-names></name><name><surname>Seillier-Moiseiwitsch</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>CO</given-names></name><name><surname>Chai</surname><given-names>TC</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment</article-title><source>Physiol Genomics</source><year>2003</year><volume>14</volume><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">12847144</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minas</surname><given-names>K</given-names></name><name><surname>Liversidge</surname><given-names>J</given-names></name></person-group><article-title>Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?</article-title><source>Crit Rev Immunol</source><year>2006</year><volume>26</volume><fpage>213</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">16928187</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>AY</given-names></name><name><surname>Endy</surname><given-names>D</given-names></name></person-group><article-title>Signal transduction. Decoding NF-kappaB signaling</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>1189</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">12424362</pub-id><pub-id pub-id-type="doi">10.1126/science.1079331</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>DE</given-names></name><name><surname>Ihekwaba</surname><given-names>AE</given-names></name><name><surname>Elliott</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>JR</given-names></name><name><surname>Gibney</surname><given-names>CA</given-names></name><name><surname>Foreman</surname><given-names>BE</given-names></name><name><surname>Nelson</surname><given-names>G</given-names></name><name><surname>See</surname><given-names>V</given-names></name><name><surname>Horton</surname><given-names>CA</given-names></name><name><surname>Spiller</surname><given-names>DG</given-names></name><etal></etal></person-group><article-title>Oscillations in NF-kappaB signaling control the dynamics of gene expression</article-title><source>Science</source><year>2004</year><volume>306</volume><fpage>704</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">15499023</pub-id><pub-id pub-id-type="doi">10.1126/science.1099962</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kraft</surname><given-names>S</given-names></name><name><surname>Fleming</surname><given-names>T</given-names></name><name><surname>Billingsley</surname><given-names>JM</given-names></name><name><surname>Lin</surname><given-names>SY</given-names></name><name><surname>Jouvin</surname><given-names>MH</given-names></name><name><surname>Storz</surname><given-names>P</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo</article-title><source>J Exp Med</source><year>2005</year><volume>201</volume><fpage>385</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">15684326</pub-id><pub-id pub-id-type="doi">10.1084/jem.20042085</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>ZF</given-names></name><name><surname>Ho</surname><given-names>DW</given-names></name><name><surname>Lau</surname><given-names>CK</given-names></name><name><surname>Lam</surname><given-names>CT</given-names></name><name><surname>Lum</surname><given-names>CT</given-names></name><name><surname>Poon</surname><given-names>RT</given-names></name><name><surname>Fan</surname><given-names>ST</given-names></name></person-group><article-title>Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages</article-title><source>Int Immunol</source><year>2005</year><volume>17</volume><fpage>1391</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">16157606</pub-id><pub-id pub-id-type="doi">10.1093/intimm/dxh316</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>TT</given-names></name><name><surname>Kong</surname><given-names>XP</given-names></name></person-group><article-title>Structural basis fortetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution</article-title><source>J Cell Biol</source><year>2006</year><volume>173</volume><fpage>975</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">16785325</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200602086</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Espana</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>PJ</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Pellicer</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>TT</given-names></name><name><surname>Desalle</surname><given-names>R</given-names></name></person-group><article-title>Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: Implications for uroplakin structure and function</article-title><source>Mol Phylogenet Evol</source><year>2006</year><pub-id pub-id-type="pmid">16814572</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>CC</given-names></name><name><surname>Liang</surname><given-names>FX</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Tu</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>CH</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Kreibich</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>TT</given-names></name></person-group><article-title>Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking</article-title><source>Mol Biol Cell</source><year>2005</year><volume>16</volume><fpage>3937</fpage><lpage>3950</lpage><pub-id pub-id-type="pmid">15958488</pub-id><pub-id pub-id-type="doi">10.1091/mbc.E05-02-0136</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Veranic</surname><given-names>P</given-names></name><name><surname>Romih</surname><given-names>R</given-names></name><name><surname>Jezernik</surname><given-names>K</given-names></name></person-group><article-title>What determines differentiation of urothelial umbrella cells?</article-title><source>Eur J Cell Biol</source><year>2004</year><volume>83</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">15085953</pub-id><pub-id pub-id-type="doi">10.1078/0171-9335-00351</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lavelle</surname><given-names>J</given-names></name><name><surname>Meyers</surname><given-names>S</given-names></name><name><surname>Ramage</surname><given-names>R</given-names></name><name><surname>Bastacky</surname><given-names>S</given-names></name><name><surname>Doty</surname><given-names>D</given-names></name><name><surname>Apodaca</surname><given-names>G</given-names></name><name><surname>Zeidel</surname><given-names>ML</given-names></name></person-group><article-title>Bladder permeability barrier: recovery from selective injury of surface epithelial cells</article-title><source>Am J Physiol Renal Physiol</source><year>2002</year><volume>283</volume><fpage>F242</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">12110507</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>TT</given-names></name></person-group><article-title>Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing</article-title><source>Am J Physiol Renal Physiol</source><year>2006</year><volume>291</volume><fpage>F9</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16609152</pub-id><pub-id pub-id-type="doi">10.1152/ajprenal.00035.2006</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>SY</given-names></name><name><surname>Shapiro</surname><given-names>E</given-names></name><name><surname>Kong</surname><given-names>XP</given-names></name><name><surname>Wu</surname><given-names>XR</given-names></name><name><surname>Sun</surname><given-names>TT</given-names></name><name><surname>Costello</surname><given-names>CE</given-names></name></person-group><article-title>Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>14644</fpage><lpage>14653</lpage><pub-id pub-id-type="pmid">16567801</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M600877200</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lavelle</surname><given-names>JP</given-names></name><name><surname>Apodaca</surname><given-names>G</given-names></name><name><surname>Meyers</surname><given-names>SA</given-names></name><name><surname>Ruiz</surname><given-names>WG</given-names></name><name><surname>Zeidel</surname><given-names>ML</given-names></name></person-group><article-title>Disruption of guinea pig urinary bladder permeability barrier in noninfectious cystitis</article-title><source>Am J Physiol</source><year>1998</year><volume>274</volume><fpage>F205</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">9458841</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>WW</given-names></name><name><surname>Lewis</surname><given-names>MM</given-names></name><name><surname>Lawson</surname><given-names>D</given-names></name><name><surname>Yin-Goen</surname><given-names>Q</given-names></name><name><surname>Birdsong</surname><given-names>GG</given-names></name><name><surname>Cotsonis</surname><given-names>GA</given-names></name><name><surname>Cohen</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>AN</given-names></name></person-group><article-title>Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression</article-title><source>Mod Pathol</source><year>2004</year><pub-id pub-id-type="pmid">15254555</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>VM</given-names></name><name><surname>Hurtado</surname><given-names>M</given-names></name><name><surname>Kort</surname><given-names>EJ</given-names></name><name><surname>Resnati</surname><given-names>M</given-names></name><name><surname>Blasi</surname><given-names>F</given-names></name><name><surname>Thomson</surname><given-names>T</given-names></name><name><surname>Paciucci</surname><given-names>R</given-names></name></person-group><article-title>Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><fpage>2203</fpage><lpage>2213</lpage><pub-id pub-id-type="pmid">16631161</pub-id><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.03.017</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laufs</surname><given-names>S</given-names></name><name><surname>Schumacher</surname><given-names>J</given-names></name><name><surname>Allgayer</surname><given-names>H</given-names></name></person-group><article-title>Urokinase-Receptor (u-PAR): An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/Dormancy, Clinical Outcome and Minimal Residual Disease</article-title><source>Cell Cycle</source><year>2006</year><volume>5</volume><pub-id pub-id-type="pmid">16931909</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>SM</given-names></name><name><surname>Lawrence</surname><given-names>T</given-names></name><name><surname>Kleiman</surname><given-names>A</given-names></name><name><surname>Warden</surname><given-names>P</given-names></name><name><surname>Medghalchi</surname><given-names>M</given-names></name><name><surname>Tuckermann</surname><given-names>J</given-names></name><name><surname>Saklatvala</surname><given-names>J</given-names></name><name><surname>Clark</surname><given-names>AR</given-names></name></person-group><article-title>Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><fpage>1883</fpage><lpage>1889</lpage><pub-id pub-id-type="pmid">16880258</pub-id><pub-id pub-id-type="doi">10.1084/jem.20060336</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeffrey</surname><given-names>KL</given-names></name><name><surname>Brummer</surname><given-names>T</given-names></name><name><surname>Rolph</surname><given-names>MS</given-names></name><name><surname>Liu</surname><given-names>SM</given-names></name><name><surname>Callejas</surname><given-names>NA</given-names></name><name><surname>Grumont</surname><given-names>RJ</given-names></name><name><surname>Gillieron</surname><given-names>C</given-names></name><name><surname>Mackay</surname><given-names>F</given-names></name><name><surname>Grey</surname><given-names>S</given-names></name><name><surname>Camps</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1</article-title><source>Nat Immunol</source><year>2006</year><volume>7</volume><fpage>274</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">16474395</pub-id><pub-id pub-id-type="doi">10.1038/ni1310</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>M</given-names></name><name><surname>Mages</surname><given-names>J</given-names></name><name><surname>Dietrich</surname><given-names>H</given-names></name><name><surname>Servatius</surname><given-names>A</given-names></name><name><surname>Howells</surname><given-names>N</given-names></name><name><surname>Cato</surname><given-names>AC</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><article-title>Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16380512</pub-id><pub-id pub-id-type="doi">10.1084/jem.20051753</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Kunapuli</surname><given-names>SP</given-names></name></person-group><article-title>Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets</article-title><source>Blood</source><year>2006</year><volume>107</volume><fpage>947</fpage><lpage>954</lpage><pub-id pub-id-type="pmid">16223779</pub-id><pub-id pub-id-type="doi">10.1182/blood-2005-07-3040</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>C</given-names></name><name><surname>Collison</surname><given-names>DJ</given-names></name><name><surname>Duncan</surname><given-names>G</given-names></name></person-group><article-title>Characterization and functional activity of thrombin receptors in the human lens</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>925</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">15728549</pub-id><pub-id pub-id-type="doi">10.1167/iovs.04-0523</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Kunapuli</surname><given-names>SP</given-names></name></person-group><article-title>Akt activation in platelets depends on Gi signaling pathways</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>4186</fpage><lpage>4195</lpage><pub-id pub-id-type="pmid">14623889</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M306162200</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>M</given-names></name><name><surname>Kumari</surname><given-names>S</given-names></name><name><surname>Chadda</surname><given-names>R</given-names></name><name><surname>Hill</surname><given-names>MM</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Mayor</surname><given-names>S</given-names></name></person-group><article-title>Arf6-independent GPI-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a Rab5/phosphatidylinositol-3'-kinase-dependent machinery</article-title><source>Mol Biol Cell</source><year>2006</year><volume>17</volume><fpage>3689</fpage><lpage>3704</lpage><pub-id pub-id-type="pmid">16760436</pub-id><pub-id pub-id-type="doi">10.1091/mbc.E05-10-0980</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cottrell</surname><given-names>GS</given-names></name><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Schmidlin</surname><given-names>F</given-names></name><name><surname>Bunnett</surname><given-names>N</given-names></name></person-group><article-title>Protease-activated receptor 2: activation, signalling and function</article-title><source>Biochem Soc Trans</source><year>2003</year><volume>31</volume><fpage>1191</fpage><lpage>1197</lpage><pub-id pub-id-type="pmid">14641024</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaborik</surname><given-names>Z</given-names></name><name><surname>Hunyady</surname><given-names>L</given-names></name></person-group><article-title>Intracellular trafficking of hormone receptors</article-title><source>Trends Endocrinol Metab</source><year>2004</year><volume>15</volume><fpage>286</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">15358282</pub-id><pub-id pub-id-type="doi">10.1016/j.tem.2004.06.009</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Lecker</surname><given-names>SH</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Waddell</surname><given-names>ID</given-names></name><name><surname>Goldberg</surname><given-names>AL</given-names></name><name><surname>Reid</surname><given-names>MB</given-names></name></person-group><article-title>TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k</article-title><source>Faseb J</source><year>2003</year><volume>17</volume><fpage>1048</fpage><lpage>1057</lpage><pub-id pub-id-type="pmid">12773487</pub-id><pub-id pub-id-type="doi">10.1096/fj.02-0759com</pub-id></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urbe</surname><given-names>S</given-names></name></person-group><article-title>Ubiquitin and endocytic protein sorting</article-title><source>Essays in biochemistry</source><year>2005</year><volume>41</volume><fpage>81</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">16250899</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roosterman</surname><given-names>D</given-names></name><name><surname>Schmidlin</surname><given-names>F</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group><article-title>Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2</article-title><source>Am J Physiol Cell Physiol</source><year>2003</year><volume>284</volume><fpage>C1319</fpage><lpage>1329</lpage><pub-id pub-id-type="pmid">12540381</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miserey-Lenkei</surname><given-names>S</given-names></name><name><surname>Couedel-Courteille</surname><given-names>A</given-names></name><name><surname>Del Nery</surname><given-names>E</given-names></name><name><surname>Bardin</surname><given-names>S</given-names></name><name><surname>Piel</surname><given-names>M</given-names></name><name><surname>Racine</surname><given-names>V</given-names></name><name><surname>Sibarita</surname><given-names>JB</given-names></name><name><surname>Perez</surname><given-names>F</given-names></name><name><surname>Bornens</surname><given-names>M</given-names></name><name><surname>Goud</surname><given-names>B</given-names></name></person-group><article-title>A role for the Rab6A' GTPase in the inactivation of the Mad2-spindle checkpoint</article-title><source>Embo J</source><year>2006</year><volume>25</volume><fpage>278</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">16395330</pub-id><pub-id pub-id-type="doi">10.1038/sj.emboj.7600929</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>B</given-names></name><name><surname>Preisinger</surname><given-names>C</given-names></name><name><surname>Schaletzky</surname><given-names>J</given-names></name><name><surname>Kopajtich</surname><given-names>R</given-names></name><name><surname>Barr</surname><given-names>FA</given-names></name></person-group><article-title>The Rab6 GTPase regulates recruitment of the dynactin complex to Golgi membranes</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>1792</fpage><lpage>1795</lpage><pub-id pub-id-type="pmid">12401177</pub-id><pub-id pub-id-type="doi">10.1016/S0960-9822(02)01221-6</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Souza-Schorey</surname><given-names>C</given-names></name><name><surname>Chavrier</surname><given-names>P</given-names></name></person-group><article-title>ARF proteins: roles in membrane traffic and beyond</article-title><source>Nat Rev Mol Cell Biol</source><year>2006</year><volume>7</volume><fpage>347</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">16633337</pub-id><pub-id pub-id-type="doi">10.1038/nrm1910</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>JG</given-names></name><name><surname>Honda</surname><given-names>A</given-names></name></person-group><article-title>Localization and function of Arf family GTPases</article-title><source>Biochem Soc Trans</source><year>2005</year><volume>33</volume><fpage>639</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">16042562</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>JG</given-names></name><name><surname>Honda</surname><given-names>A</given-names></name><name><surname>Weigert</surname><given-names>R</given-names></name></person-group><article-title>Multiple activities for Arf1 at the Golgi complex</article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1744</volume><fpage>364</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">15979507</pub-id><pub-id pub-id-type="doi">10.1016/j.bbamcr.2005.03.001</pub-id></citation></ref><ref id="B83"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Lavezzari</surname><given-names>G</given-names></name><name><surname>Roche</surname><given-names>KW</given-names></name></person-group><article-title>Constitutive endocytosis of the metabotropic glutamate receptor mGluR7 is clathrin-independent</article-title><source>Neuropharmacology</source><year>2006</year></citation></ref><ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Schuff-Werner</surname><given-names>P</given-names></name><name><surname>Steiner</surname><given-names>M</given-names></name></person-group><article-title>Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>343</volume><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">16530725</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.02.136</pub-id></citation></ref><ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Mueller</surname><given-names>BM</given-names></name></person-group><article-title>Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>344</volume><fpage>1263</fpage><lpage>1270</lpage><pub-id pub-id-type="pmid">16650817</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.04.005</pub-id></citation></ref><ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arisato</surname><given-names>T</given-names></name><name><surname>Sarker</surname><given-names>KP</given-names></name><name><surname>Kawahara</surname><given-names>K</given-names></name><name><surname>Nakata</surname><given-names>M</given-names></name><name><surname>Hashiguchi</surname><given-names>T</given-names></name><name><surname>Osame</surname><given-names>M</given-names></name><name><surname>Kitajima</surname><given-names>I</given-names></name><name><surname>Maruyama</surname><given-names>I</given-names></name></person-group><article-title>The agonist of the protease-activated receptor-1 (PAR) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human smooth muscle cells</article-title><source>Cell Mol Life Sci</source><year>2003</year><volume>60</volume><fpage>1716</fpage><lpage>1724</lpage><pub-id pub-id-type="pmid">14513837</pub-id><pub-id pub-id-type="doi">10.1007/s00018-003-3140-6</pub-id></citation></ref><ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uzonyi</surname><given-names>B</given-names></name><name><surname>Lotzer</surname><given-names>K</given-names></name><name><surname>Jahn</surname><given-names>S</given-names></name><name><surname>Kramer</surname><given-names>C</given-names></name><name><surname>Hildner</surname><given-names>M</given-names></name><name><surname>Bretschneider</surname><given-names>E</given-names></name><name><surname>Radke</surname><given-names>D</given-names></name><name><surname>Beer</surname><given-names>M</given-names></name><name><surname>Vollandt</surname><given-names>R</given-names></name><name><surname>Evans</surname><given-names>JF</given-names></name><etal></etal></person-group><article-title>Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2006</year><volume>103</volume><fpage>6326</fpage><lpage>6331</lpage><pub-id pub-id-type="pmid">16606835</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0601223103</pub-id></citation></ref><ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelso</surname><given-names>EB</given-names></name><name><surname>Lockhart</surname><given-names>JC</given-names></name><name><surname>Hembrough</surname><given-names>T</given-names></name><name><surname>Dunning</surname><given-names>L</given-names></name><name><surname>Plevin</surname><given-names>R</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name><name><surname>Sommerhoff</surname><given-names>CP</given-names></name><name><surname>McLean</surname><given-names>JS</given-names></name><name><surname>Ferrell</surname><given-names>WR</given-names></name></person-group><article-title>Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation</article-title><source>J Pharmacol Exp Ther</source><year>2006</year><volume>316</volume><fpage>1017</fpage><lpage>1024</lpage><pub-id pub-id-type="pmid">16260582</pub-id><pub-id pub-id-type="doi">10.1124/jpet.105.093807</pub-id></citation></ref><ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darrow</surname><given-names>AL</given-names></name><name><surname>Fung-Leung</surname><given-names>WP</given-names></name><name><surname>Ye</surname><given-names>RD</given-names></name><name><surname>Santulli</surname><given-names>RJ</given-names></name><name><surname>Cheung</surname><given-names>WM</given-names></name><name><surname>Derian</surname><given-names>CK</given-names></name><name><surname>Burns</surname><given-names>CL</given-names></name><name><surname>Damiano</surname><given-names>BP</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Keenan</surname><given-names>CM</given-names></name><etal></etal></person-group><article-title>Biological consequences of thrombin receptor deficiency in mice</article-title><source>Thromb Haemost</source><year>1996</year><volume>76</volume><fpage>860</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">8972001</pub-id></citation></ref><ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Hingamp</surname><given-names>P</given-names></name><name><surname>Quackenbush</surname><given-names>J</given-names></name><name><surname>Sherlock</surname><given-names>G</given-names></name><name><surname>Spellman</surname><given-names>P</given-names></name><name><surname>Stoeckert</surname><given-names>C</given-names></name><name><surname>Aach</surname><given-names>J</given-names></name><name><surname>Ansorge</surname><given-names>W</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Causton</surname><given-names>HC</given-names></name><etal></etal></person-group><article-title>Minimum information about a microarray experiment (MIAME)-toward standards for microarray data</article-title><source>Nat Genet</source><year>2001</year><volume>29</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">11726920</pub-id><pub-id pub-id-type="doi">10.1038/ng1201-365</pub-id></citation></ref><ref id="B91"><citation citation-type="other"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GPL151"/></citation></ref><ref id="B92"><citation citation-type="other"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/"/></citation></ref><ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Ways</surname><given-names>JA</given-names></name><name><surname>Barbato</surname><given-names>JC</given-names></name><name><surname>Essig</surname><given-names>D</given-names></name><name><surname>Pettee</surname><given-names>K</given-names></name><name><surname>DeRaedt</surname><given-names>SJ</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Weaver</surname><given-names>DA</given-names></name><name><surname>Koch</surname><given-names>LG</given-names></name><name><surname>Cicila</surname><given-names>GT</given-names></name></person-group><article-title>Gene expression profiling of the left ventricles in a rat model of intrinsic aerobic running capacity</article-title><source>Physiol Genomics</source><year>2005</year><volume>23</volume><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">16033863</pub-id><pub-id pub-id-type="doi">10.1152/physiolgenomics.00251.2004</pub-id></citation></ref><ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macfarlane</surname><given-names>SR</given-names></name><name><surname>Seatter</surname><given-names>MJ</given-names></name><name><surname>Kanke</surname><given-names>T</given-names></name><name><surname>Hunter</surname><given-names>GD</given-names></name><name><surname>Plevin</surname><given-names>R</given-names></name></person-group><article-title>Proteinase-activated receptors</article-title><source>Pharmacological reviews</source><year>2001</year><volume>53</volume><fpage>245</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">11356985</pub-id></citation></ref><ref id="B95"><citation citation-type="other"><ext-link ext-link-type="uri" xlink:href="http://www.genpathway.com."/></citation></ref><ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Labhart</surname><given-names>P</given-names></name><name><surname>Karmakar</surname><given-names>S</given-names></name><name><surname>Salicru</surname><given-names>EM</given-names></name><name><surname>Egan</surname><given-names>BS</given-names></name><name><surname>Alexiadis</surname><given-names>V</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name></person-group><article-title>Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>1339</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">15677324</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0409578102</pub-id></citation></ref><ref id="B97"><citation citation-type="other"><ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi"/></citation></ref><ref id="B98"><citation citation-type="other"><ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/"/></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>A. PAR1-dependent genes</bold>. Inflammation was induced by intravesical instillation of substance P or LPS into the bladder of WT and PAR1<sup>-/- </sup>mice and compared to control (saline-treated); see methods for details. Twenty-four hours after, bladders were removed and the RNA was isolated for cDNA array experiments. Genes that were upregulated in response to inflammation in wild type mice and failed to be up-regulated in PAR1<sup>-/- </sup>mice were considered to be PAR-1 dependent transcripts. PAR-1 dependent transcripts were used to query the Ingenuity Pathways Analysis [IPA] and based on EntrezGene and Gene Ontology annotations were distributed into relevant biological compartments and biological interactions.</p></caption><graphic xlink:href="1472-6793-7-3-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Participation of PAR1-dependent genes in canonical pathways</bold>. The experimental datasets of PAR1-dependent genes was used to query the Ingenuity Pathways Analysis [IPA] and overlaid to canonical pathways.</p></caption><graphic xlink:href="1472-6793-7-3-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Primary functions associated with PAR1-dependent genes</bold>. The experimental datasets of PAR1-dependent genes was used to query the Ingenuity Pathways Analysis [IPA] and overlaid with primary functions and diseases.</p></caption><graphic xlink:href="1472-6793-7-3-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p>Functions and disease shared by PAR1-depend transcripts.</p></caption><graphic xlink:href="1472-6793-7-3-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-Based Assays</bold>. For target validation, female C57BL/6J mice (n = 20 per group) were instilled with 200 &#x003bc;l of one of the following substances: control inactive peptide (LRGILS [94]) or PAR-activating peptides (PAR1-AP = SFFLRN [94]; PAR2-AP = SLIGRL [94]). Twenty-four hours after instillation, bladders were removed and frozen. Bladders were exposed briefly to formaldehyde for cross-linking of the proteins and DNA together, followed by sonication to fragment the DNA. An antibody against RNA polymerase II (Abcam) was then used to precipitate the DNA transcriptome that was isolated and then purified using phenol extraction and EtOH precipitation. The final CHIP DNAs were then used as templates for Q-PCR reactions using primer pairs specific for each gene of interest, additional material 2 (Table 2). Q-PCRs were run in triplicate and the averaged Ct values were transferred into copy numbers of DNA using a standard curve of genomic DNA with known copy numbers. The resulting transcription values for each gene were also normalized for primer pair amplification efficiency using the Q-PCR values obtained with Input DNA (un-precipitated genomic DNA). Results are presented as "transcription events detected per 1000 cells" for each gene tested. Error bars correspond to standard deviations from the triplicate Q-PCR reactions. Control represents an un-transcribed region of the genome. Asterisks indicate a statistical significant difference (p &#x0003c; 0.05).</p></caption><graphic xlink:href="1472-6793-7-3-5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>PAR-APs induce up-regulation of iPLA<sub>2 </sub>in the mouse urinary bladder</bold>. Cytoplasmic extract from the bladder mucosa of wild type mice instilled with PAR-APs- or control peptide were subjected to Western Blot analysis to measure relative concentration of iPLA<sub>2</sub>. Results are representative of four separate experiments.</p></caption><graphic xlink:href="1472-6793-7-3-6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p>Average densitometric values of PAR-APs induce up-regulation of iPLA<sub>2 </sub>in the mouse urinary bladder (Figure 6).</p></caption><graphic xlink:href="1472-6793-7-3-7"/></fig></sec></back></article> 